The bill orders the President to withdraw the United States from the Constitution of the World Health Organization and prohibits federal departments and agencies from using any funds to support U.S. participation in the WHO or any successor organization. It also repeals the 1948 statute that authorized U.S. membership and appropriations for the WHO.
This is a near-total statutory severing of the United States’ formal relationship with the WHO: it removes the domestic authorization for membership, forbids future federal funding for participation, and compels executive action to effect withdrawal. For professionals in public health, diplomacy, global health finance, and regulatory compliance, the bill raises immediate operational, legal, and budgetary questions about obligations, existing commitments, and ongoing collaboration with WHO networks.
At a Glance
What It Does
On enactment the bill directs the President to withdraw the United States from the Constitution of the World Health Organization (cited in the bill) and bars any federal department or agency from using funds to provide for U.S. participation in the WHO or any successor organization. It also repeals the June 14, 1948 statute (Public Law 806–43; 22 U.S.C. 290 et seq.) that authorized membership and appropriations.
Who It Affects
Federal agencies that fund or staff WHO programs, U.S. international health programs and grants that flow through WHO mechanisms, diplomatic missions, and U.S. participants in WHO technical networks and treaty bodies. International partners and NGOs that rely on U.S. assessed and voluntary contributions will also be affected.
Why It Matters
The bill would end the legal basis for U.S. membership and funding, removing U.S. voice from WHO governance and potentially disrupting surveillance, supply chains, standard-setting, and joint responses to cross-border health threats. It also creates legal and administrative questions about existing obligations, previously appropriated funds, and informal collaboration channels that agencies commonly use.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill contains three short but consequential moves. First, it instructs the President to withdraw the United States from the WHO Constitution.
That is a direction to terminate formal treaty-based membership rather than a narrow funding cut. Second, it imposes an immediate statutory ban on the use of any federal funds to provide for U.S. participation in the WHO or any successor organization.
Third, it repeals the 1948 Act that provided statutory authorization for U.S. membership and appropriations tied to the WHO.
Operationally, withdrawal would remove U.S. representation on WHO governing bodies, end access to certain WHO-managed procurement and distribution arrangements, and likely terminate U.S. participation in WHO technical networks and standard-setting processes that rely on member-state engagement. The funding prohibition is broad: it applies to any federal department or agency and extends to participation in successor organizations, which creates legal ambiguity about future multilateral arrangements built around the WHO’s functions.The statute does not include transitional provisions.
It does not address assessed contributions already invoiced or paid, the treatment of U.S. personnel assigned to WHO posts, the status of U.S.-funded WHO contracts or grants in progress, or how the United States would continue informal technical collaboration with WHO experts. Those omissions create immediate implementation questions for agencies, contractors, and international partners that rely on U.S. partnership in WHO activities.
The Five Things You Need to Know
The bill directs the President to withdraw the United States from the Constitution of the World Health Organization effective on the date of enactment (the WHO Constitution is cited: 62 Stat. 2679; 14 U.N.T.S. 186).
It prohibits any funds available to any federal department or agency from being used to provide for U.S. participation in the WHO or any successor organization, with no express exceptions or transition period.
The bill repeals the Act of June 14, 1948 (Public Law 806–43; 62 Stat. 441; 22 U.S.C. 290 et seq.), which currently authorizes U.S. membership and appropriations for the WHO.
The text contains no provisions addressing assessed contributions already owed or paid, nor does it lay out how to handle U.S. personnel, existing contracts, or grant obligations tied to WHO programs.
The prohibition extends to participation in any successor organization, a broadly phrased restriction that could constrain future multilateral health arrangements that perform WHO-like functions.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Provides the Act’s name, the "WHO Withdrawal Act." This is procedural and ceremonial but establishes the bill’s purpose for interpretive contexts (e.g., rulemaking or implementing guidance referencing the statutory title).
Withdrawal directive and funding prohibition
This is the operative core. Paragraph (1) commands the President to withdraw the United States from the WHO Constitution. Paragraph (2) bars any funds available to federal departments or agencies from being used to provide for U.S. participation in the WHO or any successor organization. Practically, that creates a concurrent executive and statutory obligation: the President must take withdrawal steps, and agencies are forbidden from spending money on participation. The provision is immediate — effective on enactment — and contains no carve-outs for ongoing contracts, emergency responses, or assessed contributions, which will drive administrative and legal friction during implementation.
Repeal of 1948 authorizing statute
Repeals the 1948 Act that authorized U.S. membership in the WHO and the related appropriation authority codified at 22 U.S.C. 290 et seq. The repeal removes the domestic statutory basis that Congress has used historically to appropriate funds for WHO obligations. Without that authorization, agencies lack statutory authority to fund membership-related activities unless Congress enacts a replacement law or otherwise funds specific activities through different authorities.
This bill is one of many.
Codify tracks hundreds of bills on Foreign Affairs across all five countries.
Explore Foreign Affairs in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Members of Congress and executive officials prioritizing unilateral control over public health policy — the bill ends formal WHO authority over U.S. participation and prevents future appropriation-driven obligations, giving domestic policymakers greater legal latitude over international health commitments.
- Domestic programs that seek to redirect funds previously channeled through multilateral WHO mechanisms — the prohibition on using federal funds for WHO participation creates the possibility that Congress or agencies could reallocate money to bilateral or domestic programs instead of multilateral channels.
- Private contractors and vendors focused exclusively on domestic public health procurement — in the absence of U.S. participation in WHO procurement or distribution mechanisms, some domestic suppliers may face reduced competition from multilateral procurement and could win more U.S.-funded business directly.
Who Bears the Cost
- U.S. public health agencies (CDC, NIH, HHS, State Department health offices) — they lose a statutory route for coordinating surveillance, technical guidance, and joint procurement with WHO and may need to build bilateral channels or new multilateral arrangements at additional cost.
- Global health programs and NGOs that depend on U.S. assessed and voluntary contributions — funding streams and program continuity (vaccine initiatives, disease eradication efforts, surveillance networks) could face shortfalls or operational disruption.
- U.S. diplomatic influence and global health leadership — removal from WHO governance means the United States forfeits voting power and formal voice in setting international health standards, which may reduce its ability to shape responses to pandemics or influence technical norms.
- U.S. researchers and laboratories that rely on WHO technical networks and data-sharing platforms — withdrawal could limit access to coordinated surveillance systems, reference laboratories, and pathogen sample sharing arrangements.
- International partners and low- and middle-income countries — they may lose a major financial and technical partner for WHO-led programs, potentially creating service gaps that fall to other donor states or organizations.
Key Issues
The Core Tension
The bill pits national control and the desire to avoid multilateral obligations against the practical need for sustained international cooperation on transnational health threats: withdrawing preserves unilateral policy autonomy but diminishes U.S. influence, access to shared surveillance and response mechanisms, and the ability to steer global health rules — a trade-off with no simple administrative fix.
The bill’s brevity creates several legal and operational gaps. It commands withdrawal but does not specify the withdrawal mechanism, timeline, or notifications required under international law or the WHO Constitution.
That gap raises questions about whether the President can comply by unilateral executive action, whether particular statutory steps are needed, and how assessed contributions already invoiced or contractually committed will be treated. Agencies will confront conflicting pressures: a statutory prohibition on future participation versus preexisting contractual or treaty-based obligations.
The broad ban on funding for "participation" and "successor organizations" is open to interpretation. Agencies might argue that technical cooperation short of formal membership (data sharing, laboratory support, emergency response coordination) is not "participation," while others will interpret the ban expansively.
The bill also removes the 1948 authorization but says nothing about reallocating funds, which transfers budgetary choice to Congress and risks underfunding critical global health functions absent a replacement. Finally, operational consequences — from supply-chain disruptions in vaccine distribution to loss of access to WHO-managed reference data — could be immediate but unevenly distributed, and the bill provides no mitigation mechanisms or transition planning.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.